| Name | Title | Contact Details |
|---|
We empower greater health. Today, we have access to highly personalized and useful information in almost every area of our lives; our money, transportation, food, exercise, entertainment, and home security yet we don’t have this same access to the data and insights contained in our personal health records. The current healthcare system is highly complex and constrains the flow of useful information; patient health data and medical records are stored in hundreds of different systems, across thousands of independent organizations in millions of different formats. We simplify this complexity to securely connect healthcare decision-makers to the clinical data and hidden insights contained in patent medical records so that they can deliver greater outcomes at lower costs.
Bethesda Gardens At Fort Worth is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Organ Recovery Systems is a Des Plaines, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Seagrove Inc. is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities surrounding diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, kidney function, residual insulin, and presence of steroids.